SANUWAVE Health, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -79.5% | +4.9% | +27.3% | -7.9% | +187.2% | +580.9% | -19.1% | +6.7% | +12.8% | +34.4% | +24.0% | |
| – | -84.2% | +43.7% | +31.8% | -10.0% | +131.1% | +216.6% | -44.5% | +50.5% | +47.8% | +88.0% | +33.9% | |
| – | -95.7% | -12.7% | +446.7% | -50.1% | +382.9% | +38.4% | -74.6% | +86.3% | +55.9% | +469.7% | +16.8% | |
| – | -95.7% | -12.7% | +446.7% | -50.1% | +382.9% | – | – | +86.3% | +55.9% | +469.7% | +16.8% | |
| – | -13.8% | +518.9% | -66.9% | +54.7% | -68.0% | +3,018.8% | +2.5% | +66.8% | -17.7% | +0.5% | +62.9% | |
| – | +4.8% | -18.6% | -0.2% | +54.5% | +51.7% | +444.4% | -64.8% | -16.5% | +240.0% | +40.6% | +43.0% | |
| – | -47.2% | +1,719.7% | -21.5% | +28.8% | +974.8% | +51.5% | -20.1% | – | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -50.0% | -100.0% | – | – | – | – | -10.8% | -12.1% | -13.7% | -15.9% | -18.9% | |
| – | +9.9% | +15.8% | +41.0% | +48.2% | -18.7% | +173.3% | +56.7% | +5.7% | +7.7% | -34.7% | -16.6% | |
| – | -76.1% | +432.0% | +41.0% | +47.7% | -24.7% | +191.4% | +55.5% | +7.0% | +7.6% | -34.6% | -57.9% | |
| – | -0.5% | +3.2% | +9.5% | +78.4% | -40.1% | – | – | +73.0% | -27.9% | -19.5% | -77.1% | |
| – | +119.7% | +40.0% | +109.9% | +6.4% | -9.6% | +209.4% | +71.6% | -42.4% | +29.7% | -34.7% | -13.7% | |
| – | – | -100.0% | – | – | – | – | +509.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +30.7% | +70.8% | +29.0% | +7.7% | +35.8% | +131.8% | +10.1% | +6.0% | +44.5% | -99.4% | +103.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.